Signals of progressive multifocal leukoencephalopathy for immunosuppressants: a disproportionality analysis of spontaneous reports within the US Adverse Event Reporting System (AERS)
Author:
Affiliation:
1. BIPS - Institute for Epidemiology and Prevention Research; Germany
2. Charité Berlin; Institute for Social Medicine, Epidemiology and Health Economics; Germany
3. Faculty for Human and Health Sciences; University of Bremen; Germany
Publisher
Wiley
Subject
Pharmacology (medical),Epidemiology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.3320/fullpdf
Reference14 articles.
1. Progressive multifocal leukoencephalopathy;Weber;Neurol Clin,2008
2. US Food and Drug Administration Public Health Advisory - Suspended Marketing of Tysabri (natalizumab) 2005 http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm051761.htm
3. US Food and Drug Administration Efalizumab (marketed as Raptiva) information 2009 http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm133337.htm
4. Progressive multifocal leukoencephalopathy and newer biological agents;Berger;Drug Saf,2010
5. Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents;Piccinni;Eur J Clin Pharmacol,2010
Cited by 59 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Intelligent Pharmacy's applications of cyclosporine;Intelligent Pharmacy;2023-12
2. Methotrexate therapy for adult and paediatric moderate‐to‐severe atopic dermatitis: A PRISMA‐compliant meta‐analysis of data from daily practice;Australasian Journal of Dermatology;2023-11-08
3. Adverse Events in NMOSD Therapy;International Journal of Molecular Sciences;2022-04-09
4. Immune profile and radiological characteristics of progressive multifocal leukoencephalopathy;European Journal of Neurology;2021-10-27
5. Neurological immunotherapy in the era of COVID-19 — looking for consensus in the literature;Nature Reviews Neurology;2020-07-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3